XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2017
Apr. 30, 2016
Current Assets    
Cash and cash equivalents $ 12,506 $ 5,222
Restricted cash 1,435 1,567
Receivables, less allowance: $191 (2017); $202 (2016) 29,889 27,835
Inventories 14,935 15,626
Prepaid expenses and other current assets 1,047 707
Total Current Assets 59,812 50,957
Property, Plant and Equipment, Net 14,027 14,118
Other Assets    
Deferred income taxes 3,158 3,392
Other 3,919 3,938
Total Other Assets 7,077 7,330
Total Assets 80,916 72,405
Current Liabilities    
Short-term borrowings and interest rate swaps 3,591 3,818
Current portion of long-term debt 918 421
Accounts payable 11,995 11,722
Employee compensation and amounts withheld 2,765 2,333
Deferred revenue 5,806 785
Other accrued expenses 1,852 1,871
Total Current Liabilities 26,927 20,950
Long-term debt 2,431 3,349
Accrued pension and deferred compensation costs 8,301 9,554
Total Liabilities 37,659 33,853
Commitments and Contingencies (Note 7)
Stockholders' Equity    
Common stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,715 shares (2017); 2,688 shares; (2016); Outstanding - 2,712 shares (2017); 2,685 shares (2016); 6,789 6,720
Additional paid-in-capital 2,695 2,375
Retained earnings 39,771 36,826
Accumulated other comprehensive loss (6,319) (7,626)
Common stock in treasury, at cost: 3 shares (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 42,883 38,242
Noncontrolling Interest 374 310
Total Equity 43,257 38,552
Total Liabilities and Stockholders' Equity $ 80,916 $ 72,405